Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0255.HK Stock Summary
Top 10 Correlated ETFs
0255.HK
In the News
0255.HK Financial details
Company Rating
Sell
Market Cap
814.86M
Income
104.11M
Revenue
3.39B
Book val./share
2.92
Cash/share
0.75
Dividend
0.16
Dividend %
12.6%
Employees
2.9K
Optionable
No
Shortable
Yes
Earnings
22 Mar 2024
P/E
50.73
Forward P/E
-
PEG
-9.37
P/S
0.55
P/B
0.4
P/C
1.57
P/FCF
-8.31
Quick Ratio
2.71
Current Ratio
6.55
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
0.17
EPS next Y
-
EPS next Q
-
EPS this Y
-93.06%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-37.87%
Revenue last 5Y
-9.1%
Revenue Q/Q
2.17%
EPS Q/Q
25.06%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
-
Gross Margin
60%
Oper. Margin
-
Profit Margin
1%
Payout
1038%
Shs Outstand
631.68M
Shs Float
174.95M
-
-
-
-
Target Price
-
52W Range
1.2-2.55
52W High
-41%
52W Low
+18%
RSI
38
Rel Volume
5.57
Avg Volume
33.76K
Volume
188K
Perf Week
-10.61%
Perf Month
-4.84%
Perf Quarter
-24.36%
Perf Half Y
-24.36%
-
-
-
-
Beta
0.441
-
-
Volatility
0.05%, 0.04%
Prev Close
0%
Price
1.18
Change
0%
0255.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.09 | 3.61 | 3.27 | 3.6 | 2.54 | |
Net income per share | 0.27 | 0.24 | 0.29 | 0.36 | 0.03 | |
Operating cash flow per share | 0.51 | 0.55 | 0.58 | 0.59 | 0.14 | |
Free cash flow per share | 0.37 | 0.42 | 0.4 | 0.27 | -0.15 | |
Cash per share | 1.15 | 1.33 | 1.58 | 1.51 | 0.93 | |
Book value per share | 3.43 | 3.35 | 3.6 | 3.6 | 3.14 | |
Tangible book value per share | 3.32 | 3.35 | 3.6 | 3.6 | 3.14 | |
Share holders equity per share | 3.43 | 3.35 | 3.6 | 3.6 | 3.14 | |
Interest debt per share | -0.04 | 0.02 | 0.02 | 0.02 | 0.02 | |
Market cap | 2.17B | 1.64B | 1.65B | 2.36B | 1.71B | |
Enterprise value | 1.52B | 897.02M | 744.34M | 1.54B | 1.18B | |
P/E ratio | 12.71 | 10.96 | 9.1 | 10.37 | 107.85 | |
Price to sales ratio | 0.84 | 0.72 | 0.8 | 1.04 | 1.07 | |
POCF ratio | 6.7 | 4.72 | 4.48 | 6.39 | 19.13 | |
PFCF ratio | 9.15 | 6.2 | 6.46 | 14.01 | -18.3 | |
P/B Ratio | 1 | 0.77 | 0.72 | 1.04 | 0.86 | |
PTB ratio | 1 | 0.77 | 0.72 | 1.04 | 0.86 | |
EV to sales | 0.59 | 0.39 | 0.36 | 0.68 | 0.74 | |
Enterprise value over EBITDA | 3.88 | 2.74 | 2.21 | 3.45 | 7.25 | |
EV to operating cash flow | 4.71 | 2.59 | 2.02 | 4.16 | 13.22 | |
EV to free cash flow | 6.42 | 3.4 | 2.92 | 9.12 | -12.65 | |
Earnings yield | 0.08 | 0.09 | 0.11 | 0.1 | 0.01 | |
Free cash flow yield | 0.11 | 0.16 | 0.15 | 0.07 | -0.05 | |
Debt to equity | -0.01 | 0.01 | 0.01 | 0 | 0 | |
Debt to assets | -0.01 | 0.01 | 0.01 | 0 | 0 | |
Net debt to EBITDA | -1.65 | -2.26 | -2.69 | -1.85 | -3.24 | |
Current ratio | 4.62 | 4.82 | 5.16 | 5.04 | 6.55 | |
Interest coverage | 0 | 361.5 | 373.64 | 635.6 | 10.67 | |
Income quality | 1.9 | 2.32 | 2.03 | 1.62 | 5.64 | |
Dividend Yield | 0.08 | 0.09 | 0.08 | 0.11 | 0.1 | |
Payout ratio | 1.04 | 0.97 | 0.73 | 1.19 | 10.38 | |
Sales general and administrative to revenue | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.03 | 0.29 | 0.27 | 0.27 | 0.32 | |
Capex to operating cash flow | -0.27 | -0.24 | -0.31 | -0.54 | -2.04 | |
Capex to revenue | -0.03 | -0.04 | -0.05 | -0.09 | -0.11 | |
Capex to depreciation | -0.48 | -0.47 | -0.77 | -1.29 | -1.15 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.56 | 4.22 | 4.82 | 5.4 | 1.33 | |
ROIC | 0.07 | 0.06 | 0.07 | 0.09 | 0 | |
Return on tangible assets | 0.07 | 0.08 | 0.09 | 0.11 | 0.01 | |
Graham Net | 1.18 | 1.4 | 1.61 | 1.57 | 1.09 | |
Working capital | 1.22B | 1.26B | 1.42B | 1.38B | 1.1B | |
Tangible asset value | 2.1B | 1.36B | 1.53B | 1.52B | 1.25B | |
Net current asset value | 1.09B | 1.14B | 1.29B | 1.24B | 979.17M | |
Invested capital | -0.01 | 0.01 | 0.01 | 0 | 0 | |
Average receivables | 300.49M | 285.32M | 287.23M | 275.44M | 215.5M | |
Average payables | 111.28M | 96.43M | 76.41M | 63.4M | 44.47M | |
Average inventory | 542.77M | 546.64M | 557.3M | 590.7M | 605.6M | |
Days sales outstanding | 37.7 | 48.73 | 47.79 | 45.04 | 34.3 | |
Days payables outstanding | 36.81 | 19.22 | 17.9 | 14.04 | 9.52 | |
Days of inventory on hand | 187.2 | 123.63 | 149.22 | 147.4 | 184.08 | |
Receivables turnover | 9.68 | 7.49 | 7.64 | 8.1 | 10.64 | |
Payables turnover | 9.92 | 18.99 | 20.39 | 26 | 38.35 | |
Inventory turnover | 1.95 | 2.95 | 2.45 | 2.48 | 1.98 | |
ROE | 0.08 | 0.07 | 0.08 | 0.1 | 0.01 | |
Capex per share | -0.14 | -0.13 | -0.18 | -0.32 | -0.29 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.88 | 1.72 | 1.44 | 1.1 | 1.12 | |
Net income per share | 0.17 | 0.19 | 0.06 | -0.04 | -0.05 | |
Operating cash flow per share | 0.44 | 0.15 | 0.04 | 0.1 | 0 | |
Free cash flow per share | 0.3 | -0.03 | -0.13 | -0.01 | -0.11 | |
Cash per share | 1.6 | 1.51 | 1.18 | 0.93 | 0.75 | |
Book value per share | 3.51 | 3.6 | 3.33 | 3.14 | 2.92 | |
Tangible book value per share | 3.51 | 3.6 | 3.33 | 3.14 | 2.92 | |
Share holders equity per share | 3.51 | 3.6 | 3.33 | 3.14 | 2.92 | |
Interest debt per share | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | |
Market cap | 2.14B | 2.36B | 2.23B | 1.71B | 1.26B | |
Enterprise value | 1.21B | 1.54B | 1.63B | 1.18B | 847.65M | |
P/E ratio | 4.94 | 4.93 | 13.6 | -16.94 | -9.97 | |
Price to sales ratio | 1.8 | 2.18 | 2.46 | 2.46 | 1.77 | |
POCF ratio | 7.75 | 25.04 | 88.52 | 26.66 | -62.86K | |
PFCF ratio | 11.3 | -116.02 | -26.15 | -215.86 | -18.64 | |
P/B Ratio | 0.96 | 1.04 | 1.06 | 0.86 | 0.68 | |
PTB ratio | 0.96 | 1.04 | 1.06 | 0.86 | 0.68 | |
EV to sales | 1.02 | 1.42 | 1.8 | 1.7 | 1.2 | |
Enterprise value over EBITDA | 5.46 | 6.88 | 12.77 | 33.97 | 28.73 | |
EV to operating cash flow | 4.4 | 16.3 | 64.83 | 18.42 | -42.38K | |
EV to free cash flow | 6.41 | -75.53 | -19.15 | -149.15 | -12.57 | |
Earnings yield | 0.05 | 0.05 | 0.02 | -0.01 | -0.03 | |
Free cash flow yield | 0.09 | -0.01 | -0.04 | 0 | -0.05 | |
Debt to equity | 0.01 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -4.16 | -3.69 | -4.67 | -15.19 | -13.88 | |
Current ratio | 4.48 | 5.04 | 5.22 | 6.55 | 6.28 | |
Interest coverage | 579.53 | 702.77 | 294.9 | -234.21 | -240.14 | |
Income quality | 2.55 | 0.79 | 0.61 | -2.54 | 0 | |
Dividend Yield | 0.08 | 0.04 | 0.06 | 0.02 | 0.03 | |
Payout ratio | 1.63 | 0.79 | 3.08 | -1.51 | -1.2 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.27 | 0.27 | 0.3 | 0.32 | 0.34 | |
Capex to operating cash flow | -0.31 | -1.22 | -4.39 | -1.12 | 3.37K | |
Capex to revenue | -0.07 | -0.11 | -0.12 | -0.1 | -0.1 | |
Capex to depreciation | -1.11 | -1.47 | -1.41 | -0.89 | -0.8 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.67 | 3.92 | 2.21 | 1.68 | 1.81 | |
ROIC | 0.05 | 0.05 | 0.02 | -0.02 | -0.02 | |
Return on tangible assets | 0.05 | 0.06 | 0.02 | -0.02 | -0.02 | |
Graham Net | 1.53 | 1.57 | 1.33 | 1.09 | 0.94 | |
Working capital | 1.36B | 1.38B | 1.2B | 1.1B | 976.02M | |
Tangible asset value | 1.48B | 1.52B | 1.36B | 1.25B | 1.12B | |
Net current asset value | 1.23B | 1.24B | 1.07B | 979.17M | 872.08M | |
Invested capital | 0.01 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 20.5 | 23.28 | 27.27 | 19.52 | 18.94 | |
Days payables outstanding | 9.19 | 6.9 | 7.07 | 5 | 5.25 | |
Days of inventory on hand | 61.35 | 72.49 | 81.12 | 96.72 | 90.69 | |
Receivables turnover | 4.39 | 3.87 | 3.3 | 4.61 | 4.75 | |
Payables turnover | 9.8 | 13.04 | 12.72 | 18 | 17.13 | |
Inventory turnover | 1.47 | 1.24 | 1.11 | 0.93 | 0.99 | |
ROE | 0.05 | 0.05 | 0.02 | -0.01 | -0.02 | |
Capex per share | -0.14 | -0.18 | -0.17 | -0.11 | -0.11 |
0255.HK Frequently Asked Questions
What is Lung Kee (Bermuda) Holdings Limited stock symbol ?
Lung Kee (Bermuda) Holdings Limited is a HK stock and trading under the symbol 0255.HK
What is Lung Kee (Bermuda) Holdings Limited stock quote today ?
Lung Kee (Bermuda) Holdings Limited stock price is $1.18 today.
Is Lung Kee (Bermuda) Holdings Limited stock public?
Yes, Lung Kee (Bermuda) Holdings Limited is a publicly traded company.